Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Buelow

Showing results (111-120 of 113) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 113 results.
Leukemia|January 13, 2025
Prognostic, biological, and structural implications of FLT3-JMD point mutations in acute myeloid leukemia: an analysis of Alliance studiesNadeen Anabtawi, Deedra Nicolet, Najla Alotaibi, et al.
JCI Insight|December 3, 2020
TP-0903 is active in models of drug-resistant acute myeloid leukemiaJae Yoon Jeon, Daelynn R Buelow, Dominique A Garrison, et al.
Nature Communications|January 18, 2019
Clinical resistance to crenolanib in acute myeloid leukemia due to diverse molecular mechanismsHaijiao Zhang, Samantha Savage, Anna Reister Schultz, et al.
Pageof 12

Showing results (111-120 of 113) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 113 results.
Leukemia|January 13, 2025
Prognostic, biological, and structural implications of FLT3-JMD point mutations in acute myeloid leukemia: an analysis of Alliance studiesNadeen Anabtawi, Deedra Nicolet, Najla Alotaibi, et al.
JCI Insight|December 3, 2020
TP-0903 is active in models of drug-resistant acute myeloid leukemiaJae Yoon Jeon, Daelynn R Buelow, Dominique A Garrison, et al.
Nature Communications|January 18, 2019
Clinical resistance to crenolanib in acute myeloid leukemia due to diverse molecular mechanismsHaijiao Zhang, Samantha Savage, Anna Reister Schultz, et al.
Pageof 12